Sorafenib Supplier-Buyer Network — Trade Flow Analysis

Name: Sorafenib Supplier-Buyer Trade Network Dataset — 203+ Indian Exporters, 12+ Importers, 98+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Sorafenib supplier network, Sorafenib buyers, pharmaceutical export India, Sorafenib trade data

TransData Nexus

Sorafenib

India Pharmaceutical Trade Intelligence

$16.6M203 Suppliers98 CountriesHS 30049049

ExportsIndia → UNITED STATES75.0%India → SAUDI ARABIA6.5%

ImportsGERMANY → India$172.7K ROMANIA → India$33.3K

#1 Buyer: TORRENT PHARMA

Who Supplies Sorafenib? Top Manufacturers & Buyers 2026 — TORRENT PHARMACEUTICALS LTD Leads | TransData Nexus | TransData Nexus

1TORRENT PHARMACEUTICALS LTD

TORRENT PHARMACEUTICALS LTD is the first-largest Sorafenib exporter from India, with a market share of 27.2% and a total export value of $4.5M across 12 shipments. Their average shipment value of $376.7K is above the market average of $18.2K, suggesting premium or bulk contract pricing.

TORRENT PHARMACEUTICALS LTD serves 1 named buyer in our database. XX RXXDY XXLABXXATOX is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• XX RXXDY XXLABXXATOX — $4.5M across 12 shipments (100.0% of this supplier's total exports)

Key Insight: TORRENT PHARMACEUTICALS LTD's per-shipment value of $376.7K is 1973% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.

2NATCO PHARMA LIMITED

NATCO PHARMA LIMITED is the second-largest Sorafenib exporter from India, with a market share of 27.2% and a total export value of $4.5M across 17 shipments. Their average shipment value of $265.8K is above the market average of $18.2K, suggesting premium or bulk contract pricing.

NATCO PHARMA LIMITED serves 1 named buyer in our database. DR REDDY S LABORATOR is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• DR REDDY S LABORATOR — $4.5M across 17 shipments (100.0% of this supplier's total exports)

Key Insight: NATCO PHARMA LIMITED's per-shipment value of $265.8K is 1363% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.

3MEDYRA PHARMACEUTICAL

MEDYRA PHARMACEUTICAL is the third-largest Sorafenib exporter from India, with a market share of 19.1% and a total export value of $3.2M across 15 shipments. Their average shipment value of $211.7K is above the market average of $18.2K, suggesting premium or bulk contract pricing.

MEDYRA PHARMACEUTICAL serves 3 named buyers in our database. TORRENT PHARMA INC is the dominant customer, accounting for 54.9% of this supplier's tracked business. Top customers include:

• TORRENT PHARMA INC — $1.7M across 8 shipments (54.9% of this supplier's total exports)

• TORRENT PHARMA INC — $1.4M across 7 shipments (45.1% of this supplier's total exports)

• TORRENT DO BRASIL LT — $3 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: MEDYRA PHARMACEUTICAL's per-shipment value of $211.7K is 1065% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.

4HEET HEALTHCARE PRIVATE LIMITED

HEET HEALTHCARE PRIVATE LIMITED is the fourth-largest Sorafenib exporter from India, with a market share of 9.5% and a total export value of $1.6M across 34 shipments. Their average shipment value of $46.3K is above the market average of $18.2K, suggesting premium or bulk contract pricing.

HEET HEALTHCARE PRIVATE LIMITED serves 5 named buyers in our database. BOSTON ONCOLOGY ARAB is the dominant customer, accounting for 68.2% of this supplier's tracked business. Top customers include:

• BOSTON ONCOLOGY ARAB — $1.1M across 23 shipments (68.2% of this supplier's total exports)

• SOPHAL SPA — $275.6K across 6 shipments (17.5% of this supplier's total exports)

• ATLANTA MEDICARE CO LTD — $134.8K across 3 shipments (8.6% of this supplier's total exports)

• ATLANTA MEDICARE CO LTD — $78.1K across 2 shipments (5.0% of this supplier's total exports)

• EVEREST BANK LTD — $11.7K across 0 shipments (0.7% of this supplier's total exports)

Key Insight: HEET HEALTHCARE PRIVATE LIMITED's per-shipment value of $46.3K is 155% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.

5JODAS EXPOIM PRIVATE LIMITED

JODAS EXPOIM PRIVATE LIMITED is the fifth-largest Sorafenib exporter from India, with a market share of 3.0% and a total export value of $492.0K across 4 shipments. Their average shipment value of $123.0K is above the market average of $18.2K, suggesting premium or bulk contract pricing.

JODAS EXPOIM PRIVATE LIMITED serves 2 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• FARMA SOLUTION SA — $246.0K across 2 shipments (50.0% of this supplier's total exports)

• NEOETHICALS S A — $246.0K across 2 shipments (50.0% of this supplier's total exports)

Key Insight: JODAS EXPOIM PRIVATE LIMITED's per-shipment value of $123.0K is 577% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.

6CIPLA LIMITED

CIPLA LIMITED is the fifth-largest Sorafenib exporter from India, with a market share of 2.6% and a total export value of $436.1K across 3 shipments. Their average shipment value of $145.4K is above the market average of $18.2K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 2 named buyers in our database. DROGUERIA SAIMED S.A is the dominant customer, accounting for 53.7% of this supplier's tracked business. Top customers include:

• DROGUERIA SAIMED S.A — $234.3K across 2 shipments (53.7% of this supplier's total exports)

• FARMA SOLUTION, SOCI — $201.8K across 1 shipments (46.3% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $145.4K is 700% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.

1United States

United States ranks as the first-largest destination for Sorafenib imports from India, with a total trade value of $12.5M across 12 shipments — representing a 75.0% share of all Sorafenib exports. The average shipment value of $1.0M is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Sorafenib importers in United States: TORRENT PHARMA INC is the largest buyer, accounting for 16.0% ($2.0M) of this market's total imports.

• TORRENT PHARMA INC — $2.0M (16.0% of United States's total)

• TORRENT PHARMA INC, — $1.4M (11.5% of United States's total)

Key Insight: United States's per-shipment average of $1.0M (5627% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Sorafenib imports from India.

Primary Market

Secondary Market

2Saudi Arabia

Saudi Arabia ranks as the second-largest destination for Sorafenib imports from India, with a total trade value of $1.1M across 0 shipments — representing a 6.5% share of all Sorafenib exports. The average shipment value of $1.1M is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations.

Key Insight: Saudi Arabia's per-shipment average of $1.1M (5826% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Saudi Arabia is a key market for Sorafenib imports from India.

Primary Market

Secondary Market

3Guatemala

Guatemala ranks as the third-largest destination for Sorafenib imports from India, with a total trade value of $447.9K across 0 shipments — representing a 2.7% share of all Sorafenib exports. The average shipment value of $447.9K is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations.

Key Insight: Guatemala's per-shipment average of $447.9K (2365% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Guatemala is a key market for Sorafenib imports from India.

Primary Market

Secondary Market

4France

France ranks as the fourth-largest destination for Sorafenib imports from India, with a total trade value of $275.6K across 0 shipments — representing a 1.7% share of all Sorafenib exports. The average shipment value of $275.6K is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations.

Key Insight: France's per-shipment average of $275.6K (1417% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Sorafenib imports from India.

Primary Market

Secondary Market

5Nicaragua

Nicaragua ranks as the fifth-largest destination for Sorafenib imports from India, with a total trade value of $264.4K across 0 shipments — representing a 1.6% share of all Sorafenib exports. The average shipment value of $264.4K is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations.

Key Insight: Nicaragua's per-shipment average of $264.4K (1356% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Nicaragua is a key market for Sorafenib imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Sorafenib.
2.Flow Mapping: 203 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 916 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 98 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

916 Verified Shipments

203 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Sorafenib

Sorafenib

Who Supplies Sorafenib? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Sorafenib? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Sorafenib Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1TORRENT PHARMACEUTICALS LTD

2NATCO PHARMA LIMITED

3MEDYRA PHARMACEUTICAL

4HEET HEALTHCARE PRIVATE LIMITED

5JODAS EXPOIM PRIVATE LIMITED

6CIPLA LIMITED

From Indian Factories to Global Pharmacies — How Sorafenib Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Sorafenib Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Saudi Arabia

3Guatemala

4France

5Nicaragua

People Also Ask — Sorafenib Supplier & Trade Network

Sorafenib Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology